MDRNA buys DNA technology from Valeant Pharmaceuticals for undisclosed amount
Biotechnology company MDRNA Inc. said Tuesday it bought DNA technology-related patents from Valeant Pharmaceuticals for an undisclosed amount.
NEW YORK Israeli drug developer Compugen Ltd. said Monday it discovered a potential cancer treatment target using its RNA sequence technology.